These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27446860)

  • 1. Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications.
    Richter JM; Arshi NK; Oster G
    Can J Gastroenterol Hepatol; 2016; 2016():6928710. PubMed ID: 27446860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study.
    Richter JM; Kushkuley S; Barrett JA; Oster G
    Aliment Pharmacol Ther; 2012 Aug; 36(3):248-56. PubMed ID: 22690748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis.
    Cortot A; Maetz D; Degoutte E; Delette O; Meunier P; Tan G; Cazals JB; Dewit O; Hebuterne X; Beorchia S; Grunberg B; Leprince E; D'Haens G; Forestier S; Idier I; Lémann M
    Am J Gastroenterol; 2008 Dec; 103(12):3106-14. PubMed ID: 19086960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.
    Andus T; Kocjan A; Müser M; Baranovsky A; Mikhailova TL; Zvyagintseva TD; Dorofeyev AE; Lozynskyy YS; Cascorbi I; Stolte M; Vieth M; Dilger K; Mohrbacher R; Greinwald R;
    Inflamm Bowel Dis; 2010 Nov; 16(11):1947-56. PubMed ID: 20310020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should maintenance therapy be performed in ulcerative proctitis? How long should it be continued?
    Yönal O; Hatemi G; Kaymakoğlu S
    Turk J Gastroenterol; 2012; 23 Suppl 2():21-4. PubMed ID: 23576086
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy for ulcerative colitis: salazosulfapyridine and 5-ASA].
    Jo Y; Matsumoto T; Iida M
    Nihon Rinsho; 2005 May; 63(5):820-4. PubMed ID: 15881176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulcerative proctitis: a review of pharmacotherapy and management.
    Lakatos PL; Lakatos L
    Expert Opin Pharmacother; 2008 Apr; 9(5):741-9. PubMed ID: 18345952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical therapy is underused in patients with ulcerative colitis.
    Seibold F; Fournier N; Beglinger C; Mottet C; Pittet V; Rogler G;
    J Crohns Colitis; 2014 Jan; 8(1):56-63. PubMed ID: 23566922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of topical 5-aminosalicylate monotherapy in patients with ulcerative proctitis with skip inflammation.
    Choi YS; Kim WJ; Kim JK; Kim DS; Lee DH
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1200-1206. PubMed ID: 29205498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of mesalazine suppositories in proctitis and distal proctosigmoiditis.
    Gionchetti P; Rizzello F; Venturi A; Brignola C; Ferretti M; Peruzzo S; Campieri M
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1053-7. PubMed ID: 9663829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term intermittent treatment with low-dose 5-aminosalicylic enemas is efficacious for remission maintenance in ulcerative colitis.
    Piodi LP; Ulivieri FM; Cermesoni L; Cesana BM
    Scand J Gastroenterol; 2004 Feb; 39(2):154-7. PubMed ID: 15000277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.
    Hanauer S; Good LI; Goodman MW; Pizinger RJ; Strum WB; Lyss C; Haber G; Williams CN; Robinson M
    Am J Gastroenterol; 2000 Jul; 95(7):1749-54. PubMed ID: 10925979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of mesalamine 1 g HS versus 500 mg BID suppositories in mild to moderate ulcerative proctitis: a multicenter randomized study.
    Lamet M; Ptak T; Dallaire C; Shah U; Grace M; Spenard J; de Montigny D;
    Inflamm Bowel Dis; 2005 Jul; 11(7):625-30. PubMed ID: 15973115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulated comparison of topical and oral formulations of 5-aminosalicylate for the treatment of ulcerative colitis.
    Stobaugh DJ; Deepak P; Thorpe M; Hannon B; Ehrenpreis ED
    Inflamm Bowel Dis; 2013 Feb; 19(2):301-8. PubMed ID: 22644716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
    Kam L; Cohen H; Dooley C; Rubin P; Orchard J
    Am J Gastroenterol; 1996 Jul; 91(7):1338-42. PubMed ID: 8677990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-stage decision analysis to assess the cost of 5-aminosalicylic acid failure and the economics of balsalazide versus mesalamine in the treatment of ulcerative colitis.
    Mackowiak JI
    Manag Care Interface; 2006 Oct; 19(10):39-46, 56. PubMed ID: 17117598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis.
    Safdi M; DeMicco M; Sninsky C; Banks P; Wruble L; Deren J; Koval G; Nichols T; Targan S; Fleishman C; Wiita B
    Am J Gastroenterol; 1997 Oct; 92(10):1867-71. PubMed ID: 9382054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. The U.S. PENTASA Enema Study Group.
    Hanauer SB
    Inflamm Bowel Dis; 1998 May; 4(2):79-83. PubMed ID: 9589293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of left-sided ulcerative colitis successfully treated with mesalazine enema but not steroid suppository].
    Yamamoto S; Miyata Y; Kato J; Hasuike S; Ideguchi T; Minami H; Hori T; Hirono S; Hayashi K; Tsubouchi H
    Nihon Shokakibyo Gakkai Zasshi; 2000 Jul; 97(7):910-3. PubMed ID: 10934875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.